XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income $ 359,786 $ 177,716
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 398,678 381,938
(Gain) loss on sale of depreciable real estate assets (134,515) 7
Gain on sale of non-depreciable real estate assets (202) (995)
(Gain) loss on embedded derivative in preferred shares (11,492) 14,603
Stock compensation expense 12,804 12,532
Amortization of debt issuance costs, discounts and premiums 4,142 3,595
Net change in operating accounts and other operating activities 49,049 54,489
Net cash provided by operating activities 678,250 643,885
Cash flows from investing activities:    
Purchases of real estate and other assets (46,028) (5,004)
Capital improvements, development and other (388,373) (288,183)
Distributions from real estate joint venture 483 207
Contributions to affiliates (1,971) (3,450)
Proceeds from disposition of real estate assets 166,234 3,278
Net cash used in investing activities (269,655) (293,152)
Cash flows from financing activities:    
Proceeds from revolving credit facility   245,000
Repayments of revolving credit facility   (245,000)
Net payments on commercial paper (147,000) (35,000)
Proceeds from notes payable 594,423 447,593
Principal payments on notes payable (466,817) (440,222)
Payment of deferred financing costs (5,922) (4,196)
Distributions to noncontrolling interests (12,009) (11,993)
Dividends paid on common shares (352,384) (342,983)
Dividends paid on preferred shares (2,766) (2,766)
Net change in other financing activities (10,214) (4,118)
Net cash used in financing activities (402,689) (393,685)
Net increase (decrease) in cash, cash equivalents and restricted cash 5,906 (42,952)
Cash, cash equivalents and restricted cash, beginning of period 35,615 70,541
Cash, cash equivalents and restricted cash, end of period 41,521 27,589
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 29,811 18,407
Restricted cash 11,710 9,182
Cash, cash equivalents and restricted cash, end of period 41,521 27,589
Supplemental disclosure of cash flow information:    
Interest paid 109,471 109,527
Income taxes paid 2,518 2,534
Supplemental disclosure of noncash investing and financing activities:    
Conversion of OP Units to shares of common stock 33,272 471
Accrued construction in progress 18,484 41,443
Interest capitalized 7,781 4,783
Limited Partner [Member]    
Cash flows from operating activities:    
Net income 359,786 177,716
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 398,678 381,938
(Gain) loss on sale of depreciable real estate assets (134,515) 7
Gain on sale of non-depreciable real estate assets (202) (995)
(Gain) loss on embedded derivative in preferred shares (11,492) 14,603
Stock compensation expense 12,804 12,532
Amortization of debt issuance costs, discounts and premiums 4,142 3,595
Net change in operating accounts and other operating activities 49,049 54,489
Net cash provided by operating activities 678,250 643,885
Cash flows from investing activities:    
Purchases of real estate and other assets (46,028) (5,004)
Capital improvements, development and other (388,373) (288,183)
Distributions from real estate joint venture 483 207
Contributions to affiliates (1,971) (3,450)
Proceeds from disposition of real estate assets 166,234 3,278
Net cash used in investing activities (269,655) (293,152)
Cash flows from financing activities:    
Proceeds from revolving credit facility   245,000
Repayments of revolving credit facility   (245,000)
Net payments on commercial paper (147,000) (35,000)
Proceeds from notes payable 594,423 447,593
Principal payments on notes payable (466,817) (440,222)
Payment of deferred financing costs (5,922) (4,196)
Dividends paid on common shares (364,393) (354,976)
Dividends paid on preferred shares (2,766) (2,766)
Net change in other financing activities (10,214) (4,118)
Net cash used in financing activities (402,689) (393,685)
Net increase (decrease) in cash, cash equivalents and restricted cash 5,906 (42,952)
Cash, cash equivalents and restricted cash, beginning of period 35,615 70,541
Cash, cash equivalents and restricted cash, end of period 41,521 27,589
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 29,811 18,407
Restricted cash 11,710 9,182
Cash, cash equivalents and restricted cash, end of period 41,521 27,589
Supplemental disclosure of cash flow information:    
Interest paid 109,471 109,527
Income taxes paid 2,518 2,534
Supplemental disclosure of noncash investing and financing activities:    
Accrued construction in progress 18,484 41,443
Interest capitalized $ 7,781 $ 4,783